Patent - Abbreviated New Drug Application Cases
Cases 11 - 20 of 47
RSS Feed | View as table | Sort by filed date
PAR PHARMACEUTICAL, INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al
as 3:2020cv18334
Defendant: AUROBINDO PHARMA U.S.A., INC. and AUROBINDO PHARMA LIMITED
Plaintiff: PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. EAGLE PHARMACEUTICALS, INC.
as 3:2020cv18319
Defendant: EAGLE PHARMACEUTICALS, INC.
Plaintiff: PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. AMNEAL EU, LIMITED et al
as 3:2020cv18322
Defendant: AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, AMNEAL BIOSCIENCES LLC, AMNEAL EU, LIMITED and others
Plaintiff: PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. Fresenius Kabi USA, LLC
as 1:2019cv01985
Plaintiff: Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Defendant: Fresenius Kabi USA, LLC
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. American Regent, Inc.
as 1:2019cv01490
Defendant: American Regent, Inc.
Plaintiff: Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. Eagle Pharmaceuticals, Inc. We have downloadable decisions or orders for this case
as 1:2018cv00823
Defendant: Eagle Pharmaceuticals, Inc.
Plaintiff: Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. Amneal Pharmaceuticals Company GmbH et al
as 1:2019cv00712
Defendant: Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceutical Holding Company LLC, Amneal Biosciences LLC and others
Plaintiff: Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc. et al v. Par Pharmaceutical, Inc.
as 1:2019cv00955
Plaintiff: Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant: Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc. et al v. PAR Pharmaceutical, Inc.
as 1:2019cv04876
Plaintiff: Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant: PAR Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc., et al. We have downloadable decisions or orders for this case
as 1:2019cv00311
Defendant: Par Pharmaceuticals, Inc. and Anchen Pharmaceuticals, Inc.
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?